Warner Chilcott US LLC Recall: Enablex (darifenacin) Extended Release Tablet, 15 mg per ta
Warner Chilcott US LLC Recall: Enablex (darifenacin) Extended Release Tablet, 15 mg per ta is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Warner Chilcott US LLC; Product: Enablex (darifenacin) Extended Release Tablet, 15 mg per tablet. Physician Sample 7 Tablets bottle, Rx only, Mfd b
| Recalling firm | Warner Chilcott US LLC |
|---|---|
| Product | Enablex (darifenacin) Extended Release Tablet, 15 mg per tablet. Physician Sample 7 Tablets bottle, Rx only, Mfd by: Novartis Pharma Stein AG, Stein, Switzerland, NDC 0078-9420-07 |
| Reason for recall | Failed Impurities/Degradation Specifications: unspecified degradation product |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Nationwide |
| Recall initiated | 20130517 |
| Recall number | D-822-2013 |
| Category | drug |
| State | NJ |
| Country | United States |
$29/mo
Try RecallGuard →